Summary Of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2021
Summary Of Significant Accounting Policies [Abstract]
Summary Of Net Revenue Disaggregated By Product And Region	Three Months Ended ‎December 31, Six Months Ended ‎December 31, 2021 2020 2021 2020U.S., Canada and Latin America Devices $ 244,775  $ 204,997  $ 520,707  $ 402,390 Masks and other 242,032  221,764  457,139  427,524 Total Sleep and Respiratory Care $ 486,807  $ 426,761  $ 977,846  $ 829,914 Software as a Service 99,034  91,833  196,551  183,976 Total $ 585,841  $ 518,594  $ 1,174,397  $ 1,013,890 Combined Europe, Asia and other markets Devices $ 207,736  $ 187,992  $ 425,961  $ 364,018 Masks and other 101,297  93,425  198,532  174,047 Total Sleep and Respiratory Care $ 309,033  $ 281,417  $ 624,493  $ 538,065 Global revenue Devices $ 452,511  $ 392,989  $ 946,668  $ 766,408 Masks and other 343,329  315,189  655,671  601,571 Total Sleep and Respiratory Care $ 795,840  $ 708,178  $ 1,602,339  $ 1,367,979 Software as a Service 99,034  91,833  196,551  183,976 Total $ 894,874  $ 800,011  $ 1,798,890  $ 1,551,955
Summary Of Contract Balances	December 31,‎2021 June 30,‎2021 Balance sheet captionContract assets Accounts receivable, net $ 526,036  $ 614,292  Accounts receivable, netUnbilled revenue, current 24,683  10,893  Prepaid expenses and other current assetsUnbilled revenue, non-current 7,593  6,214  Prepaid taxes and other non-current assets     Contract liabilities Deferred revenue, current (111,647) (109,611) Deferred revenue (current liabilities)Deferred revenue, non-current (94,427) (91,496) Deferred revenue (non-current liabilities)
Schedule Of Components Of Lease Revenue	Three Months Ended‎December 31, Six Months Ended‎December 31, 2021 2020 2021 2020Sales-type lease revenue $ 1,565  $ 1,863  $ 5,652  $ 3,823 Operating lease revenue 24,426  25,026  49,583  49,805 Total lease revenue $ 25,991  $ 26,889  $ 55,235  $ 53,628